The Effect of Medication Delivery Analgesia on Neonatal Hyperbilirubine-mia
Objective To explore and analyze the effect of drug delivery analgesia on neonatal hyperbilirubinemia.Methods A total of 200 neonates born naturally in Haining Maternal and Child Health Hospital from December 2022 to July 2023 were randomly selected as the research objects.According to the different analgesia methods used by mothers during delivery,they were divided into study group(n=100,neonates with drug labor analgesia)and control group(n=100,neonates with natural delivery without drug labor analgesia).The transcutaneous bilirubinometry(TcB)of the two groups of newborns on the 1st to 5th day after birth was evaluated,and the incidence of hyperbiliru-binemia and complications were counted.Results TcB on the 1st and 2nd day of birth in the study group[(4.90±0.79),(8.30±1.34)]were higher than that in the control group[(4.67±0.83),(7.53±1.41)],and the differences were statistically significant(t=2.007,3.958,both P<0.05).There were no significant differences in the TcB on the 3rd to 5th day of birth,the incidence of hyperbilirubinemia and complications between the study group and the control group(all P>0.05).Conclusion The effect of medication delivery analgesia on the incidence of hyperbilirubinemia and complications is comparable to that of non medication delivery analgesia,but medication delivery analgesia can improve the transcutaneous bilirubin index of newborns in the first two days.
Drug delivery analgesiaNeonatal hyperbilirubinemiaTranscutaneous bilirubinometrySerum total bilirubin
万方数据
维普
